Articles From: Citadel Federal Credit Union Chooses Symitar to NeoGenomics, the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and the Northwestern Medicine Developmental Therapeutics Institute Launch Collaborative Translational Research Program

- $2 billion credit union converts to Episys for its trustworthy reputation, ongoing innovation - MONETT, Mo.
Sign-up for Citadel Federal Credit Union Chooses Symitar investment picks
IRVINE, Calif., Dec.
Sign-up for CombiMatrix Launches Targeted Array for Prenatal Analysis investment picks
Please replace the caption with the accompanying corrected caption: T-Mobile executives John Legere, right, and Mike Sievert, left, host a media briefing announcing Un-carrier 8.0 Data Stash, Tuesday, Dec 16, 2014, in New York.
Sign-up for CORRECTING AND REPLACING CAPTION T-Mobile CEO John Legere, CMO Mike Sievert and CTO Neville Ray Answer Media Questions on Un-carrier 8.0 Data Stash (Photos) Available on Business Wire's Website and AP PhotoExpress investment picks
Barnes & Noble, Inc. ( NYSE:BKS) , the nation’s largest retail bookseller and the leading retailer of content, digital media and educational products, invites all last-minute holiday shoppers to visit Barnes & Noble stores nationwide and online at to find a wide variety of the most meaningful gifts for everyone on their list.
Sign-up for Countdown to the Holidays: Barnes & Noble Has the Perfect Gifts for Last-Minute Holiday Shoppers investment picks
Cubic Corporation (NYSE: CUB) today announced the acquisition of DTECH LABS, Inc. (DTECH), a leading provider of modular networking and baseband communications equipment based in Sterling, Va., for up to $114.5 million, including $15 million of contingent consideration and subject to the terms of the stock purchase agreement.
Sign-up for Cubic acquires DTECH LABS, Inc. investment picks
- DSMB determined that the planned futility boundary has been crossed; but saw no reason for patients to discontinue from study - BERKELEY HEIGHTS, N.J., Dec.
Sign-up for Cyclacel Announces Enrollment of 486 Patients, DSMB Recommendations and That the Seamless Phase 3 Trial of Sapacitabine in AML Will Continue to Final Analysis investment picks
Datalink (NASDAQ: DTLK), a leading provider of data center infrastructure and services, today announced the successful completion of a data storage and disaster recovery infrastructure upgrade project for the City of Riverside, California.
Sign-up for Datalink Upgrades City of Riverside’s Storage & Disaster Recovery Infrastructure investment picks
Sign-up for Deadline in Lawsuit for Investors in SandRidge Energy Inc. (SD) Shares Announced by Shareholders Foundation investment picks
Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Valganciclovir Tablets USP 450 mg, a therapeutic equivalent generic version of VALCYTE ® (Valganciclovir) tablets in the US market on December 15, 2014, approved by the United States Food & Drug Administration (USFDA). The VALCYTE ® (Valganciclovir) tablets brand had U.S. sales of approximately $440 Million MAT for the most recent twelve months ending in October 2014 according to IMS Health*. Dr.
Sign-up for Dr. Reddy’s Announces the Launch of Valganciclovir Tablets, USP investment picks CALGARY, AB--(Marketwired - December 16, 2014) - Encana (TSX: ECA) (NYSE: ECA) today announced a highly focused 2015 capital program of between $2.7 billion and $2.9 billion, with approximately 80 percent directed to four of its highest margin growth plays; the Montney, Duvernay, Eagle Ford and Permian.
Sign-up for Encana Focuses 2015 Capital Program on Four Strategic Growth Assets investment picks
HERNDON, Va., Dec.
Sign-up for ePlus Completes Type 2 SSAE 16 Examination for OneSource Family of Software Products investment picks
Equity Residential (NYSE: EQR) today announced that its Board of Trustees declared dividends on the company’s common and preferred shares.
Sign-up for Equity Residential Declares Fourth Quarter Dividends investment picks
The company's latest products rapidly address evolving food trends and consumer tastes MINNEAPOLIS , Dec.
Sign-up for General Mills announces strong product lineup in the queue for the New Year investment picks
Sign-up for Hamilton Beach Brands, Inc. Announces Acquisition of Weston Products investment picks
Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) and Covance Inc. (Covance) (NYSE: CVD) jointly announced today the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act, in connection with the previously announced merger agreement under which LabCorp will acquire all of the outstanding common stock of Covance.
Sign-up for Hart-Scott-Rodino Waiting Period Expires for LabCorp Acquisition of Covance investment picks
-- ICL to invest up to $500 million for 50% ownership of a joint venture that will operate a fully integrated, world-scale phosphate business in China and a 15% strategic holding in Yunnan Yuntianhua, Asia's leading producer of phosphate rock.
Sign-up for ICL Makes A Step Change In Its Global Phosphate Business By Forming A Strategic Alliance With China's Yunnan Yuntianhua investment picks
Regulatory News: Ipsen (Euronext:IPN; ADR: IPSEY) today announced that Somatuline ® Depot ® (lanreotide) Injection 120 mg (referred to as Somatuline ® ) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with unresectable, well- or moderately-differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Marc de Garidel, Chairman and Chief Executive Officer of Ipsen stated: “I am pleased with the approval by the FDA of this new indication for Somatuline ® , which is a testimony to the scientific quality of those clinical results.
Sign-up for Ipsen’s Somatuline® Depot® is the First Therapy Approved by the FDA in the United States for the Treatment of Patients with Locally Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumors investment picks
Clean Energy Fuels Corp ., (NASDAQ: CLNE ) today announced it will design, build and operate a compressed natural gas (CNG) fueling station for the Jacksonville Transportation Authority (JTA). The deal, valued at $8.1 million, will also include facility modifications to accommodate the conversion of JTA’s buses from diesel to CNG.
Sign-up for Jacksonville Transportation Authority Awards Clean Energy $8.1 Million Deal; Additional Fueling Agreements with Clean Energy Announced investment picks
By Laura He, MarketWatch Shanghai stocks buck the weak regional trend HONG KONG (MarketWatch) -- Japan stocks continued to slide on Tuesday, falling to their lowest settlement in more than six weeks, as the yen headed higher against the greenback.
Sign-up for Japan stocks slide to six-week low as yen advances investment picks
Sign-up for Liberty Property Trust Announces Financial Projections and Updates Fourth Quarter 2014 Activity investment picks
Sign-up for LightInTheBox Extends Share Repurchase Program investment picks
Masco Corporation (NYSE: MAS) announced that its Board of Directors declared a quarterly dividend of $.09 per common share, payable on February 9, 2015, to shareholders of record on January 9, 2015.
Sign-up for Masco Corporation Declares Quarterly Dividend investment picks
More than one-third (34 percent) of Americans who seek counseling for mental health issues experience barriers that make it difficult or impossible to receive services, according to a recent survey from University of Phoenix® College of Social Sciences.
Sign-up for More Than One-Third of Americans Who Seek Mental Health Counseling Face Barriers, Finds University of Phoenix Survey investment picks
By Sue Chang, MarketWatch SAN FRANCISCO (MarketWatch) -- Among the companies whose shares are expected to see active trade in Tuesday's session are Navistar International Corp., Darden Restaurants Inc., and Dave & Buster's Entertainment Inc. Navistar(NAV) is projected to post fiscal fourth-quarter earnings of 7 cents a share, according to a consensus survey by FactSet.
Sign-up for Navistar, Darden, Dave & Buster's earnings in focus investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.


Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Citadel Federal Credit Union Chooses Symitar to NeoGenomics, the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and the Northwestern Medicine Developmental Therapeutics Institute Launch Collaborative Translational Research Program
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent